EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial seeks better treatment for aggressive childhood cancer
Disease control OngoingThis study is for children and young adults (up to age 40) with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. It compares the current standard chemotherapy to the same chemotherapy plus a newer drug called temsirolimus. The goal is to see if adding temsirolimus hel…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough childhood cancers: major trial tests drug combo against aggressive muscle tumors
Disease control OngoingThis study compares two chemotherapy combinations for children and young adults with high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer. Researchers want to see if adding a drug called vinorelbine to standard treatment helps keep the cancer from returning better than…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists search for genetic clues in childhood muscle cancer
Knowledge-focused OngoingThis study aims to understand the genetic factors that might contribute to two types of childhood muscle cancer, called rhabdomyosarcoma. Researchers are collecting saliva samples from children diagnosed with this cancer and both of their parents to look for inherited genetic cha…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC